161 related articles for article (PubMed ID: 27464727)
1. Membrane Transporters in Physiological Barriers of Pharmacological Importance.
Nagy I; Tóth B; Gáborik Z; Erdo F; Krajcsi P
Curr Pharm Des; 2016; 22(35):5347-5372. PubMed ID: 27464727
[TBL] [Abstract][Full Text] [Related]
2. Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition.
Sugiura T; Kato Y; Tsuji A
J Control Release; 2006 Nov; 116(2):238-46. PubMed ID: 16876283
[TBL] [Abstract][Full Text] [Related]
3. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
4. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
5. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
Döring B; Petzinger E
Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
[TBL] [Abstract][Full Text] [Related]
6. Pre-Plated Cell Lines for ADMETox Applications in the Pharmaceutical Industry.
Torres FM; Sáfár Z; Vázquez-Sánchez MA; Kurunczi A; Kis E; Magnan R; Jani M; Nicolás O; Krajcsi P
Curr Protoc Toxicol; 2015 Aug; 65():23.8.1-23.8.23. PubMed ID: 26250397
[TBL] [Abstract][Full Text] [Related]
7. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
König J; Müller F; Fromm MF
Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
[TBL] [Abstract][Full Text] [Related]
8. The biological and clinical role of drug transporters at the intestinal barrier.
Oostendorp RL; Beijnen JH; Schellens JH
Cancer Treat Rev; 2009 Apr; 35(2):137-47. PubMed ID: 18986769
[TBL] [Abstract][Full Text] [Related]
9. Transporter effects on cell permeability in drug delivery.
Mandal A; Agrahari V; Khurana V; Pal D; Mitra AK
Expert Opin Drug Deliv; 2017 Mar; 14(3):385-401. PubMed ID: 27449574
[TBL] [Abstract][Full Text] [Related]
10. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
11. Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood-brain barrier.
Hashimoto Y; Michiba K; Maeda K; Kusuhara H
J Pharmacol Sci; 2022 Jan; 148(1):142-151. PubMed ID: 34924119
[TBL] [Abstract][Full Text] [Related]
12. Role of nuclear receptors in the regulation of drug transporters in the brain.
Chan GN; Hoque MT; Bendayan R
Trends Pharmacol Sci; 2013 Jul; 34(7):361-72. PubMed ID: 23769624
[TBL] [Abstract][Full Text] [Related]
13. ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine.
Villanueva S; Zhang W; Zecchinati F; Mottino A; Vore M
Curr Med Chem; 2019; 26(7):1155-1184. PubMed ID: 29589524
[TBL] [Abstract][Full Text] [Related]
14. Assessment of ABCG2-mediated transport of xenobiotics across the blood-milk barrier of dairy animals using a new MDCKII in vitro model.
Wassermann L; Halwachs S; Baumann D; Schaefer I; Seibel P; Honscha W
Arch Toxicol; 2013 Sep; 87(9):1671-82. PubMed ID: 23652544
[TBL] [Abstract][Full Text] [Related]
15. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
Mao Q; Lai Y; Wang J
Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
[TBL] [Abstract][Full Text] [Related]
16. Expression, activity and pharmacokinetic impact of ocular transporters.
Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
Brand W; Schutte ME; Williamson G; van Zanden JJ; Cnubben NH; Groten JP; van Bladeren PJ; Rietjens IM
Biomed Pharmacother; 2006 Nov; 60(9):508-19. PubMed ID: 16978825
[TBL] [Abstract][Full Text] [Related]
18. Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.
Terasaki T; Ohtsuki S
NeuroRx; 2005 Jan; 2(1):63-72. PubMed ID: 15717058
[TBL] [Abstract][Full Text] [Related]
19. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
20. Xenobiotic transporter-adaptor network.
Kato Y
Drug Metab Pharmacokinet; 2007 Dec; 22(6):401-8. PubMed ID: 18159127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
